A new approach to RNA sequencing reveals thousands of previously inaccessible RNA fragments in blood plasma that might serve as disease- and organ-specific biomarkers.

Researchers have shown how tumor-associated macrophages release compounds that block gemcitabine in the most common type of pancreatic cancer

More funding, scientific insights and clinical advances have started to drive progress in this challenging disease, and researchers see potential for immunotherapy to revolutionize its future.

Awareness of genetic testing is low, a new study finds. But an interactive website can help newly diagnosed patients make informed decisions about the practice.

Each year, first-year Michigan medical students are prepped for one of the most difficult tasks they’ll face in their field: breaking bad news.

Researchers and clinicians use patients’ DNA and RNA to target and treat cancer — offering a new approach to personalized treatment.